Target intelligence / Profile preview

Mycobacterium tuberculosis 50S ribosomal subunit (Mtb 50S ribosome)

Target
Mtb 50S ribosome
Molecular classification
Ribonucleoprotein, Enzyme, Ribosome
01

Overview

The Mycobacterium tuberculosis 50S ribosomal subunit is the larger component of the bacterial 70S ribosome, serving as the primary site for peptidyl transferase activity and the exit tunnel for nascent polypeptide chains (PubMed: 32814900). It is a complex ribonucleoprotein assembly composed of 23S ribosomal RNA (rRNA), 5S rRNA, and approximately 33 ribosomal proteins, providing a structural framework essential for bacterial protein synthesis. This subunit is a critical therapeutic target in the treatment of tuberculosis, particularly for multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains. Antibiotics such as oxazolidinones (e.g., linezolid) bind to the 50S subunit to inhibit the formation of the 70S initiation complex, thereby halting the production of essential bacterial proteins (StatPearls: NBK539793). However, the clinical utility of these drugs is often limited by the emergence of resistance through mutations in the 23S rRNA or ribosomal proteins, as well as potential host toxicities resulting from structural similarities between bacterial and human mitochondrial ribosomes (PubMed: 25135897, PubMed: 22247127).

Other names
Large ribosomal subunit50S subunitM. tuberculosis 50S ribosome23S rRNA-protein complex
02

Mechanism of action

Inhibition of the initiation of translation or peptidyl transferase activity by binding to the 50S ribosomal subunit, preventing the formation of the 70S initiation complex or blocking the elongation of the polypeptide chain.

03

Biological functions

Protein synthesisTranslationPeptidyl transferase activityPolypeptide exit tunnel formation
04

Disease associations

TuberculosisInfection
05

Safety considerations

Myelosuppression (anemia, thrombocytopenia, leukopenia)Peripheral neuropathyOptic neuropathyMitochondrial toxicitySerotonin syndrome (specifically with linezolid due to MAO inhibition)
06

Interacting drugs

Linezolid

7 more in the full profile.

07

Biomarkers

rrl (23S rRNA) gene mutationsrplC (L3 protein) gene mutationsSputum culture conversionTime to positivity (TTP) in liquid culture

Beyond the preview

Go deeper on Mycobacterium tuberculosis 50S ribosomal subunit (Mtb 50S ribosome).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterium tuberculosis 50S ribosomal subunit (Mtb 50S ribosome).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call